FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

871701001: Sacituzumab govitecan (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3973908017 Sacituzumab govitecan en Synonym Active Entire term case insensitive SNOMED CT core module
3973909013 Sacituzumab govitecan (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sacituzumab govitecan Has disposition Topoisomerase inhibitor true Inferred relationship Existential restriction modifier
Sacituzumab govitecan Is a Substance with topoisomerase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Sacituzumab govitecan Is modification of Sacituzumab false Inferred relationship Existential restriction modifier
Sacituzumab govitecan Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Sacituzumab govitecan Is a Enzyme inhibitor protein true Inferred relationship Existential restriction modifier
Sacituzumab govitecan Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing sacituzumab govitecan (medicinal product) Has active ingredient True Sacituzumab govitecan Inferred relationship Existential restriction modifier 1
Sacituzumab govitecan Has active ingredient True Sacituzumab govitecan Inferred relationship Existential restriction modifier 1
Product containing sacituzumab govitecan in parenteral dose form (medicinal product form) Has active ingredient True Sacituzumab govitecan Inferred relationship Existential restriction modifier 1
Product containing only sacituzumab govitecan in parenteral dose form (medicinal product form) Has active ingredient True Sacituzumab govitecan Inferred relationship Existential restriction modifier 1
Sacituzumab govitecan 180mg powder for solution for infusion vials Has specific active ingredient True Sacituzumab govitecan Inferred relationship Existential restriction modifier
Sacituzumab govitecan 180mg powder for solution for infusion vials 1 vial Has specific active ingredient True Sacituzumab govitecan Inferred relationship Existential restriction modifier
Trodelvy 180mg powder for concentrate for solution for infusion vials (Gilead Sciences Ltd) Has specific active ingredient True Sacituzumab govitecan Inferred relationship Existential restriction modifier
Trodelvy 180mg powder for concentrate for solution for infusion vials (Gilead Sciences Ltd) 1 vial Has specific active ingredient True Sacituzumab govitecan Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start